Search
Search
Close this search box.
Search
Close this search box.

Faith Anderson

Understanding and Managing Adverse Events in Patients Treated with Tepezza

Tepezza (teprotumumab) has emerged as a groundbreaking treatment for thyroid eye disease, offering hope to patients with this rare condition. Approved by the FDA in January 2020, Tepezza has shown […]

Understanding and Managing Adverse Events in Patients Treated with Tepezza Read More »

New Study Reveals Link Between Ozempic, Similar Drugs and Increased Risk of Stomach Paralysis, Pancreatitis

Ozempic and similar drugs have become increasingly popular for the treatment of Type 2 diabetes and weight loss. However, a new study published in the Journal of the American Medical

New Study Reveals Link Between Ozempic, Similar Drugs and Increased Risk of Stomach Paralysis, Pancreatitis Read More »

Bard Implantable Port Lawsuit: A Closer Look at Port-a-Caths and Their Risks

In recent years, there has been a significant increase in the number of product liability lawsuits related to Bard implantable port devices, commonly known as port-a-caths. Port-a-caths, manufactured by companies

Bard Implantable Port Lawsuit: A Closer Look at Port-a-Caths and Their Risks Read More »

Suboxone Lawsuit Filed Over Tooth Decay Side Effects

Suboxone, a medication commonly prescribed for opioid addiction, has recently come under scrutiny for its potential to cause serious dental problems in patients. One individual, David Sorensen, recently filed a

Suboxone Lawsuit Filed Over Tooth Decay Side Effects Read More »

Pulmonary Embolism, Migration to the Heart Leads to Bard Infuse-A-Port Lawsuit

In the world of medical treatments, port-a-caths, also known as implantable ports or subcutaneous ports, have become a common tool for delivering medications and fluids directly into a patient’s bloodstream.

Pulmonary Embolism, Migration to the Heart Leads to Bard Infuse-A-Port Lawsuit Read More »

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma

Earlier this week, pharmaceutical and biotechnology giant Bayer was ordered to pay $332 million in damages to a man who claimed his cancer was caused by exposure to the company’s

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma Read More »

Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial

In a significant blow to pharmaceutical giant Bayer AG, a Philadelphia jury on Friday ordered the company to pay $175 million in damages in a trial involving their widely-used weed

Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial Read More »

The Slow Progression of Camp Lejeune Lawsuits and the Rise of Wrongful Death Claims

Camp Lejeune, a United States Marine Corps base located in Jacksonville, North Carolina, has become synonymous with a tragic chapter in the history of military environmental health hazards. The base’s

The Slow Progression of Camp Lejeune Lawsuits and the Rise of Wrongful Death Claims Read More »

Baby Formula and Necrotizing Enterocolitis: Understanding the Risks and Brands Involved

Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease that primarily affects premature infants. It is a devastating condition that can lead to long-term health complications and, in some cases, even

Baby Formula and Necrotizing Enterocolitis: Understanding the Risks and Brands Involved Read More »

Scroll to Top